Protagonist Therapeutics, Inc. (PTGX)

105.98 +2.25 (+2.17%) USD  |  NASDAQ  |  Apr 17, 16:00
106.05 +0.07 (+0.07%) After-Hours: 20:00
More

Protagonist Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Johnson & Johnson Upgrade
AbbVie, Inc. Upgrade
Insmed, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade